Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Indoco Remedies gets USFDA EIR for Patalganga facility

Indoco Remedies receives warning letter from USFDA for Goa facility

Written By Ruchika Sharma17 Dec 2024 4:04 PM IST

Mumbai: Indoco Remedies has received a warning letter from the US Food and Drug Administration (USFDA) for the company's Plant II & Plant III...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

USFDA nod to Granules India arm for ADHD treatment

Written By Ruchika Sharma17 Dec 2024 1:30 PM IST

Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign...

Serum Institute Gets NPPA Nod to Discontinue Two Pack Sizes of Tetanus Toxoid Vaccine

SII to manufacture Bavarian Nordic Mpox Vaccine

Written By Ruchika Sharma17 Dec 2024 12:30 PM IST

SII will be responsible for seeking and maintaining regulatory approval of the vaccine in India.

Cipla Recalls Cancer Drug Nilotinib in US Over Manufacturing Issue

Zydus, Aurobindo Pharma and 1 other recall products in US over manufacturing issues

Written By Ruchika Sharma16 Dec 2024 3:59 PM IST

New Delhi: USA-based subsidiaries of Aurobindo Pharma, Glenmark and Zydus are recalling products in the US over manufacturing...

USFDA approves Caplin Steriles eye drop

Written By Ruchika Sharma16 Dec 2024 2:30 PM IST

Chennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval by the...

GlGSKs Efimosfermin Secures USFDA Breakthrough, EMA PRIME Tags for MASH

Jemperli bags USFDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer: GSK

Written By Ruchika Sharma16 Dec 2024 1:30 PM IST

London: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Jemperli...

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood

Thane: Spurious drugs worth Rs 1.85 crore seized, 2 booked

Written By Ruchika Sharma16 Dec 2024 12:30 PM IST

Thane: Spurious drugs worth Rs 1.85 crore have been seized by the Food and Drug Administration (FDA) personnel. The seizure followed raids...

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Approval of Biocon Biologics Yesintek recommended by EMA Committee

Written By Ruchika Sharma16 Dec 2024 11:30 AM IST

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...

Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness

Written By Ruchika Sharma15 Dec 2024 1:15 PM IST

Basel: Roche has announced that the European Medicines Agency has approved Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use...

Alembic buys UTI-focused Utility Therapeutics in USD 12 million deal

AbbVie concludes acquisition of Aliada Therapeutics

Written By Ruchika Sharma15 Dec 2024 10:00 AM IST

North Chicago, Ill: AbbVie has announced that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition, Aliada...

Bayer new drug application for gadoquatrane accepted for review in China

Bayer acquires HiDoc Technologies, Cara Care app for irritable bowel syndrome

Written By Ruchika Sharma14 Dec 2024 4:00 PM IST

Leverkusen: Bayer has announced that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of...

Aurobindo Pharmas Eugia Unit-I Gets 4 USFDA Observations

Aurobindo Pharma arm gets positive opinion from EMA Committee for Zefylti for neutropenia treatment

Written By Ruchika Sharma14 Dec 2024 12:30 PM IST

Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced that the Committee for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok